Regulator plans cost-benefit collaboration with Italian doctors
This article was originally published in Scrip
Executive Summary
Italy's medicines regulator and one of the country's largest associations of general practitioners are making joint plans to study the cost-effectiveness of pharmaceutical products used in primary care.